Key facts
- Paradigm Health (Healthcare Technology Systems)’s last known valuation is $443.0M (Dec 2025).
- It has raised $281.0M across 1 recorded rounds; the latest was Early Stage VC (Series B1) ($78.0M) in Dec 2025.
- Notable investors include General Catalyst, Mubadala Investment Company, GV, F-Prime Capital, Lux Capital — 14 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Paradigm Health (Healthcare Technology Systems)
Funding rounds
1 roundsAbout Paradigm Health (Healthcare Technology Systems)
Operator of a health technology platform intended to serve the clinical research ecosystem. The company's platform aims to streamline the clinical trial process for patients and connect biopharmaceutical trial sponsors and healthcare providers, enabling the healthcare sector to enhance trial efficiency, reduce the barriers to participation for healthcare providers, and bring potentially life-saving therapies to patients faster.
- Industry
- Other Healthcare Technology Systems
- Sector
- Healthcare
- HQ
- Columbus, OH, United States
- Founded
- 2021
- Employees
- 148
- Website
- paradigmhealth.ai/
- Ownership
- Privately Held (backing)
Paradigm Health (Healthcare Technology Systems) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Paradigm Health (Healthcare Technology Systems) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Paradigm Health (Healthcare Technology Systems) in its N-PORT filings yet. We sweep new filings monthly.